aspartic acid has been researched along with curcumin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, DF; Lu, LN; Qiu, MF; Wu, HB; Xin, X; Zhou, Y | 1 |
| Dong, ZX; Gu, T; Li, NG; Lu, YT; Sun, Y; Wu, WY; Yu, SP; Zhong, Y | 1 |
| Cheng, R; Li, X; Liu, J; Liu, Z; Sun, N; Tian, Z; Yang, Z; Zhao, C | 1 |
| Hamadanian, M; Ma'mani, L; Rahmatolahzadeh, R; Shafiee, A | 1 |
| Jayakannan, M; Saxena, S | 1 |
| Fu, D; Guo, R; Hou, W; Li, Q; Li, T; Liu, Y; Niu, B; Wang, H; Zhang, J | 1 |
| Chen, W; Lu, Y; Meng, LP; Shi, Y; Wang, XJ; Wu, Q; Xu, XL | 1 |
1 review(s) available for aspartic acid and curcumin
| Article | Year |
|---|---|
Development and Structural Modification of BACE1 Inhibitors.
Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid; Aspartic Acid Endopeptidases; Curcumin; Enzyme Inhibitors; Gene Expression; Humans; Hydrophobic and Hydrophilic Interactions; Neuroprotective Agents; Peptidomimetics; Piperazines; Structure-Activity Relationship; Terpenes | 2016 |
6 other study(ies) available for aspartic acid and curcumin
| Article | Year |
|---|---|
[Preparation, characterization and Calu-3 cellular uptake of three kinds of poly(b-benzyl-L-amino)block-poly(ethylene glycol) nanoparticles].
Topics: Adenocarcinoma; Administration, Intranasal; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid; Cell Line, Tumor; Cell Survival; Curcumin; Drug Carriers; Ethylene Glycol; Humans; Lung Neoplasms; Lysine; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglutamic Acid | 2013 |
pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells.
Topics: Animals; Antineoplastic Agents; Aspartic Acid; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Curcumin; Drug Carriers; Drug Liberation; Drug Synergism; Female; Humans; Hydrogen-Ion Concentration; Imidazoles; Mice, Inbred BALB C; Micelles; Nanoparticles; Neoplastic Stem Cells; Paclitaxel; Particle Size; Polyethylene Glycols; Polyvinyls; Surface Properties | 2017 |
Aspartic acid functionalized PEGylated MSN@GO hybrid as an effective and sustainable nano-system for in-vitro drug delivery.
Topics: Aspartic Acid; Cell Death; Cell Survival; Curcumin; Drug Delivery Systems; Drug Liberation; Dynamic Light Scattering; Graphite; Humans; MCF-7 Cells; Nanoparticles; Polyethylene Glycols; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared; Static Electricity; Temperature; Thermogravimetry; X-Ray Diffraction | 2018 |
Development of l-Amino-Acid-Based Hydroxyl Functionalized Biodegradable Amphiphilic Polyesters and Their Drug Delivery Capabilities to Cancer Cells.
Topics: Acetals; Antineoplastic Agents; Aspartic Acid; Biocompatible Materials; Curcumin; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fluorescent Dyes; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Nanoparticles; Oxazines; Polyesters; Solubility | 2020 |
Poly(aspartic acid)-based pH-responsive targeting co-delivery nanoparticles.
Topics: Aspartic Acid; Curcumin; Doxorubicin; Drug Delivery Systems; Humans; Hyaluronic Acid; Hydrogen-Ion Concentration; Nanoparticles; Neoplasms; Particle Size; Peptides; Tumor Microenvironment | 2021 |
Arginine-Glycine-Aspartic Acid-anchored Curcumin-based Nanotherapeutics Inhibit Pyroptosis-induced Cytokine Release Syndrome for
Topics: Aspartic Acid; Curcumin; Cytokine Release Syndrome; Humans; Inflammasomes; Oligopeptides; Pyroptosis; Sepsis | 2023 |